• Kim Hyong, Chief Medical Officer of Alignment Healthcare, Inc. (NASDAQ: ALHC), sold 16,506 shares at $21.35 each, following a previous sale of 12,694 shares.
• Despite the sales, Kim Hyong retains a significant stake in the company, holding 333,133 shares after the transactions.
• Alignment Healthcare's financial metrics indicate challenges, with a negative P/E ratio of -203.72 and a debt-to-equity ratio of 2.04, but a relatively healthy current ratio of 1.61.

Alignment Healthcare, Inc. (NASDAQ: ALHC) is a healthcare company that focuses on providing healthcare services to seniors. It operates primarily through its Medicare Advantage plans, aiming to improve patient outcomes and reduce healthcare costs. The company competes with other healthcare providers in the Medicare Advantage space, striving to offer comprehensive and affordable healthcare solutions.

On January 6, 2026, Kim Hyong, the Chief Medical Officer of Alignment Healthcare, sold 16,506 shares of the company's common stock at approximately $21.35 each. This transaction follows a series of sales by Kim, including a recent sale on December 29th of 12,694 shares at an average price of $18.74, totaling around $237,886. These sales reflect a strategic reduction in Kim's holdings.

Despite these sales, Kim Hyong still holds a significant number of shares in the company. After the January transaction, Kim retains 333,133 shares. Previously, after the December sale, Kim held 349,639 shares valued at approximately $6.55 million. This indicates a 3.50% reduction in Kim's holdings, as highlighted by the recent transactions.

Alignment Healthcare's financial metrics reveal some challenges. The company has a negative price-to-earnings (P/E) ratio of -203.72, indicating negative earnings. The price-to-sales ratio is 1.17, suggesting investors are willing to pay $1.17 for every dollar of sales. The enterprise value to sales ratio is slightly lower at 1.09, reflecting the company's valuation in relation to its sales.

The company's financial health is further illustrated by its debt-to-equity ratio of 2.04, indicating more than twice as much debt as equity. However, the current ratio of 1.61 suggests a good level of liquidity to cover short-term liabilities. Despite the negative earnings yield of -0.49%, the enterprise value to operating cash flow ratio of 21.88 shows the company's ability to cover its enterprise value with operating cash flow.